The Cooper Companies, Inc. (COO) Interest Coverage Ratio: 6.83x
The interest coverage ratio for The Cooper Companies, Inc. (COO) is 6.83x as of Sunday, June 14, 2026.
COO Interest Coverage Ratio Metrics
INTEREST COVERAGE RATIO
6.83x
COO Competitors' Interest Coverage Ratio
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| The Cooper Companies, Inc. (COO) | $13.24B | 6.83x | N/A | N/A | N/A |
| Solventum Corporation (SOLV) | $13.66B | 6.29x | 4.55x | 4.55x | 4.55x |
| Align Technology, Inc. (ALGN) | $12.52B | N/A | 67.41x | 66.08x | 407.22x |
| Baxter International Inc. (BAX) | $10.77B | -1.06x | 0.71x | 2.65x | 6.89x |
| Walgreens Boots Alliance, Inc. (WBA) | $10.37B | -29.20x | 3.03x | 3.75x | 5.52x |
| Hologic, Inc. (HOLX) | $16.97B | 16.73x | 11.98x | 11.81x | 13.87x |
| Charles River Laboratories International, Inc. (CRL) | $9.03B | 4.74x | 3.27x | 5.51x | 5.84x |
| Tempus AI, Inc. (TEM) | $8.35B | -3.40x | N/A | N/A | N/A |
| Bio-Rad Laboratories, Inc. (BIO) | $7.73B | 5.52x | 5.51x | 7.63x | 62.06x |
| Moderna, Inc. (MRNA) | $19.80B | -307.40x | 531.75x | 531.75x | 531.75x |
Financial Health Indicators
Interest Coverage
6.8x
Debt/Equity
0.34
Current Ratio
1.89
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
- < 1.5x: EBIT is less than 1.5 times interest expense
- 1.5x - 3x: EBIT is between 1.5 and 3 times interest expense
- 3x - 5x: EBIT is between 3 and 5 times interest expense
- > 5x: EBIT is more than 5 times interest expense
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
The Cooper Companies, Inc. Interest Coverage Ratio Formula & Definition
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
The Cooper Companies, Inc. Interest Coverage Ratio FAQ
- What is the interest coverage ratio for The Cooper Companies, Inc. (COO)?
- The interest coverage ratio for COO stock is 6.83x.
About The Cooper Companies, Inc.
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Albert G. White